ReviewNeurology and therapy2019

Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology.

Lih-Fen Lue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.